Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax:


 Company News
Upsher-Smith Laboratories Release: Systematic Review Presented At 68th Annual Meeting Of The American Epilepsy Society Points To Need For Expert Consensus On Seizure Cluster Nomenclature And Diagnosis 12/8/2014 9:01:30 AM
Upsher-Smith Laboratories Presents New Data From Year-Long, Open-Label Extension Study Of Qudexy XR (Topiramate) Extended-Release Capsules At 68th Annual American Epilepsy Society Meeting 12/8/2014 8:59:45 AM
Upsher-Smith Laboratories To Present New Data At 2014 American Epilepsy Society Annual Meeting 11/25/2014 10:54:40 AM
Upsher-Smith Laboratories, In Conjunction With National Epilepsy Awareness Month, Launches New Website For People Affected By Seizure Clusters, A Rare Seizure Pattern 11/3/2014 9:08:45 AM
Upsher-Smith Laboratories Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes 10/23/2014 9:21:53 AM
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014 8:22:53 AM
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014 9:44:32 AM
Upsher-Smith Laboratories Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations 7/2/2014 8:46:43 AM
Upsher-Smith Laboratories Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types 6/30/2014 8:52:44 AM
Upsher-Smith Laboratories Release: Qudexy™ XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia 6/17/2014 10:30:04 AM